Evolution and diversification of carboxylesterase-like [4+2] cyclases in aspidosperma and iboga alkaloid biosynthesis

• Published in: Proceedings of the National Academy of Sciences - PNAS Vol. 121; no. 7; p. e2318586121
• Main Authors: DeMars, Matthew D., O’Connor, Sarah E.
• Format: Journal Article
• Language: English
• Published: United States National Academy of Sciences 13.02.2024
• Subjects: Alkaloids; Aspidosperma - metabolism; Biological Sciences; Biosynthesis; Carboxylesterase; Carboxylesterase - metabolism; Catharanthus - metabolism; Chimeras; Cycloaddition; Enzymes; Evolution; Indole Alkaloids - metabolism; Metabolic pathways; Metabolites; Natural products; Phylogeny; Plants - metabolism; Protein families; Secologanin Tryptamine Alkaloids - chemistry; Secologanin Tryptamine Alkaloids - metabolism; Tabernaemontana - metabolism; natural product biosynthesis; ancestral sequence reconstruction; cycloaddition; monoterpene indole alkaloids
• ISSN: 0027-8424; 1091-6490
• DOI: 10.1073/pnas.2318586121

Monoterpene indole alkaloids (MIAs) are a large and diverse class of plant natural products, and their biosynthetic construction has been a subject of intensive study for many years. The enzymatic basis for the production of aspidosperma and iboga alkaloids, which are produced exclusively by members of the Apocynaceae plant family, has recently been discovered. Three carboxylesterase (CXE)-like enzymes from Catharanthus roseus and Tabernanthe iboga catalyze regio- and enantiodivergent [4+2] cycloaddition reactions to generate the aspidosperma (tabersonine synthase, TS) and iboga (coronaridine synthase, CorS; catharanthine synthase, CS) scaffolds from a common biosynthetic intermediate. Here, we use a combined phylogenetic and biochemical approach to investigate the evolution and functional diversification of these cyclase enzymes. Through ancestral sequence reconstruction, we provide evidence for initial evolution of TS from an ancestral CXE followed by emergence of CorS in two separate lineages, leading in turn to CS exclusively in the Catharanthus genus. This progression from aspidosperma to iboga alkaloid biosynthesis is consistent with the chemotaxonomic distribution of these MIAs. We subsequently generate and test a panel of chimeras based on the ancestral cyclases to probe the molecular basis for differential cyclization activity. Finally, we show through partial heterologous reconstitution of tabersonine biosynthesis using non-pathway enzymes how aspidosperma alkaloids could have first appeared as “underground metabolites” via recruitment of promiscuous enzymes from common protein families. Our results provide insight into the evolution of biosynthetic enzymes and how new secondary metabolic pathways can emerge through small but important sequence changes following co-option of preexisting enzymatic functions.